H H Sherry Chow

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. doi request reprint Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers
    Iman A Hakim
    The University of Arizona Cancer Center, Tucson, AZ, USA
    Cancer Epidemiol Biomarkers Prev 21:2193-200. 2012
  2. ncbi request reprint Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E
    H H Chow
    Arizona Cancer Center, The University of Arizona, Tucson 85724, USA
    Cancer Epidemiol Biomarkers Prev 10:53-8. 2001
  3. pmc Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 3:1168-75. 2010
  4. pmc Pharmacokinetic and chemoprevention studies on tea in humans
    H H Sherry Chow
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, United States
    Pharmacol Res 64:105-12. 2011
  5. ncbi request reprint Modulation of human glutathione s-transferases by polyphenon e intervention
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 16:1662-6. 2007
  6. ncbi request reprint Effects of repeated green tea catechin administration on human cytochrome P450 activity
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 15:2473-6. 2006
  7. ncbi request reprint Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724, USA
    Clin Cancer Res 11:4627-33. 2005
  8. ncbi request reprint Direct nose-brain transport of benzoylecgonine following intranasal administration in rats
    H H Chow
    Arizona Cancer Center and Department of Pharmacy Practice and Science, The University of Arizona, Tucson, Arizona 85724, USA
    J Pharm Sci 90:1729-35. 2001
  9. ncbi request reprint Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724, USA
    Cancer Epidemiol Biomarkers Prev 11:1472-6. 2002
  10. pmc Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer
    Jessica A Miller
    The University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 6:577-84. 2013

Detail Information

Publications31

  1. doi request reprint Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers
    Iman A Hakim
    The University of Arizona Cancer Center, Tucson, AZ, USA
    Cancer Epidemiol Biomarkers Prev 21:2193-200. 2012
    ....
  2. ncbi request reprint Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E
    H H Chow
    Arizona Cancer Center, The University of Arizona, Tucson 85724, USA
    Cancer Epidemiol Biomarkers Prev 10:53-8. 2001
    ..The systemic availability of EGCG increased at higher doses, possibly due to saturable presystemic elimination of orally administered green tea polyphenols...
  3. pmc Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 3:1168-75. 2010
    ..Further clinical development of resveratrol for cancer prevention should consider evaluation of lower doses of resveratrol to minimize adverse metabolic drug interactions...
  4. pmc Pharmacokinetic and chemoprevention studies on tea in humans
    H H Sherry Chow
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, United States
    Pharmacol Res 64:105-12. 2011
    ..Emerging data from multiple ongoing intervention trials will further contribute to defining the cancer preventive activity of green tea or green tea catechins...
  5. ncbi request reprint Modulation of human glutathione s-transferases by polyphenon e intervention
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 16:1662-6. 2007
    ..We conducted this clinical study to determine the effect of repeated green tea polyphenol administration on a major group of detoxification enzymes, glutathione S-transferases (GST)...
  6. ncbi request reprint Effects of repeated green tea catechin administration on human cytochrome P450 activity
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Epidemiol Biomarkers Prev 15:2473-6. 2006
    ..We conducted this clinical study to determine the effect of repeated green tea catechin administration on human cytochrome P450 (CYP) enzyme activities...
  7. ncbi request reprint Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724, USA
    Clin Cancer Res 11:4627-33. 2005
    ..Tea catechin concentrations in plasma and urine samples collected after dosing were determined by high-pressure liquid chromatography analysis...
  8. ncbi request reprint Direct nose-brain transport of benzoylecgonine following intranasal administration in rats
    H H Chow
    Arizona Cancer Center and Department of Pharmacy Practice and Science, The University of Arizona, Tucson, Arizona 85724, USA
    J Pharm Sci 90:1729-35. 2001
    ..Factors contributing to the observed differences in the nose-brain transport of cocaine and benzoylecgonine are discussed...
  9. ncbi request reprint Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724, USA
    Cancer Epidemiol Biomarkers Prev 11:1472-6. 2002
    ..07 to 32.59 (micro M) x h. Our study illustrates that the major metabolite of d-limonene is bioavailable after oral consumption of a citrus preparation rich in d-limonene content...
  10. pmc Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer
    Jessica A Miller
    The University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 6:577-84. 2013
    ..Furthermore, placebo-controlled clinical trials and translational research are warranted to establish limonene's role for breast cancer prevention or treatment...
  11. ncbi request reprint Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes
    Iman A Hakim
    Mel and Enid Zuckerman Arizona College of Public Health, University of Arizona and Arizona Cancer Center, Tucson, Arizona 85724, USA
    Cancer Epidemiol Biomarkers Prev 13:242-9. 2004
    ..This finding also suggests that green tea intervention may be effective in the subgroup of smokers who are GSTM1 and/or GSTT1 positive...
  12. ncbi request reprint Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724, USA
    Clin Cancer Res 9:3312-9. 2003
    ..In an exploratory fashion, we have also determined the effect of chronic green tea polyphenol administration on UV-induced erythema response...
  13. ncbi request reprint Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study
    Iman A Hakim
    Mel and Enid Zuckerman Arizona College of Public Health, University of Arizona, Tucson, AZ 85724, USA
    J Nutr 133:3303S-3309S. 2003
    ..These data suggest that regular green tea drinking might protect smokers from oxidative damages and could reduce cancer risk or other diseases caused by free radicals associated with smoking...
  14. pmc Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention
    Patricia Thompson
    University of Arizona Cancer Center, 1515 N Campbell Avenue, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 5:1381-93. 2012
    ..Intervention effects on adenoma recurrence will be determined, and their modification by genetic background and baseline selenium level. The effect of selenium supplementation on risk for type II diabetes will also be reported...
  15. ncbi request reprint Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content
    Jessica A Miller
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA
    Nutr Cancer 62:783-8. 2010
    ..009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction...
  16. ncbi request reprint Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography
    H H Sherry Chow
    Arizona Cancer Center, The University of Arizona, 1515 N Campbell Avenue, Tucson, AZ 85724 5024, USA
    J Pharm Biomed Anal 34:167-74. 2004
    ..S.D. for the assay was less than 12 and 5%, respectively. This assay has been applied to the analysis of celecoxib levels in plasma samples collected from healthy participants entered into a Phase II clinical study...
  17. ncbi request reprint Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial
    Denise H Frank
    Arizona Cancer Center, and Section of Hematology and Oncology, Department of Medicine, College of Medicine, University of Arizona, Tucson, Arizona 85724, USA
    Cancer Epidemiol Biomarkers Prev 13:299-303. 2004
    ..In future Phase III chemoprevention trials of celecoxib, weight gain should be carefully monitored, and participants should be made aware of this potential side effect before study entry...
  18. ncbi request reprint Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid
    Lisa M Hess
    Arizona Cancer Center, University of Arizona Health Sciences Center, 1515 North Campbell Avenue, POB 245024, Tucson, AZ 85724 5024, USA
    Cancer Epidemiol Biomarkers Prev 13:861-7. 2004
    ....
  19. ncbi request reprint Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography-tandem mass spectrometry
    Wade M Chew
    Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, United States
    J Chromatogr B Analyt Technol Biomed Life Sci 844:235-9. 2006
    ..7-11.1%) and accuracy (% difference of 2.2-6.8%) were obtained. The assay has been successfully applied to the analysis of buspirone levels in more than 500 human plasma samples collected from a drug interaction study...
  20. ncbi request reprint Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats
    Yan Cai
    College of Pharmacy, University of Arizona, Tucson, Arizona 85724, USA
    Drug Metab Dispos 30:1246-9. 2002
    ....
  21. ncbi request reprint Interaction of dacarbazine and imexon, in vitro and in vivo, in human A375 melanoma cells
    Betty K Samulitis
    College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724 5024, USA
    Anticancer Res 31:2781-5. 2011
    ..We evaluated mechanisms of interaction between the alkyating agent dacarbazine (DTIC) and the pro-oxidant, imexon, in the human A375 melanoma cell line...
  22. pmc Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial
    Patricia A Thompson
    Arizona Cancer Center, University of Arizona, Tucson, 85724 5024, USA
    Cancer Prev Res (Phila) 3:101-7. 2010
    ..038). These results are the first to show partitioning of sulindac and metabolites to human breast tissue and the first evidence for a potential dose-dependent effect of sulindac on growth differentiation factor 15 levels in NAF...
  23. pmc Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia
    Francisco A R Garcia
    Center of Excellence in Women s Health, The University of Arizona, Tucson, AZ 85724, United States University of Arizona Cancer Center, Tucson, AZ 85724, United States
    Gynecol Oncol 132:377-82. 2014
    ....
  24. pmc Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer
    Setsuko K Chambers
    University of Arizona Cancer Center, Tucson, Arizona 85724, USA
    Clin Cancer Res 18:2668-78. 2012
    ..This phase I trial evaluated intraperitoneal (i.p.) pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer...
  25. pmc Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities
    Mike M Nguyen
    Division of Urology, College of Medicine, The University of Arizona, Tucson, AZ 85724, USA
    Cancer Prev Res (Phila) 5:290-8. 2012
    ....
  26. ncbi request reprint Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype
    Iman A Hakim
    Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ 85724, USA
    J Nutr 138:1567S-1571S. 2008
    ..Our finding also suggests that green tea intervention might be effective in decreasing DNA damage in the subgroup of smokers who are GSTM1 positive regardless of their hOGG1 genotype...
  27. ncbi request reprint Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates
    Eileen C Callaway
    Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, AZ 85724, USA
    Cancer Lett 204:23-31. 2004
    ..These findings are consistent with our previous results regarding cellular export of another anticarcinogenic ITC, sulforaphane, and suggest a common cellular response to ITCs...
  28. ncbi request reprint Phase I trial of imexon in patients with advanced malignancy
    Tomislav Dragovich
    College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    J Clin Oncol 25:1779-84. 2007
    ..The purpose of this trial was to define the maximum-tolerated dose (MTD), toxicities, pharmacokinetics, and pharmacodynamics of imexon in patients with advanced cancers...
  29. pmc Determination of d-limonene in adipose tissue by gas chromatography-mass spectrometry
    Jessica A Miller
    Department of Nutritional Sciences, The University of Arizona, Tucson, AZ 85721, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 870:68-73. 2008
    ..7 to 3.8%) and between-day precision (R.S.D. 6.0-10.7%) and accuracy (%difference of 1.8-2.6%) were achieved. The assay was successfully applied to human fat biopsy samples from a d-limonene feeding trial...
  30. pmc Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer
    Arthur Y Shaw
    College of Pharmacy, University of Arizona, Tucson, Arizona, USA
    J Pharmacol Exp Ther 331:636-47. 2009
    ..5 h, and cytotoxic drug concentrations of >3 muM were achieved in vivo in mice. The diaryl oxazole series of compounds represent a new chemical class of anticancer agents that inhibit several types of cancer-relevant protein kinases...
  31. ncbi request reprint A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
    Ramesh K Ramanathan
    Division of Hematology Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Clin Cancer Res 13:2109-14. 2007
    ..Objectives of this study were to determine safety, tolerability, pharmacodynamics, and pharmacokinetics of PX-12, a small-molecule inhibitor of Trx-1...